Abstract
Background:
In the United States, 45% of people enrolled in hospice have dementia. We know little about how hospice professionals facilitate preference-aligned end-of-life care for people with dementia (PWD) and their families.
Objective:
To examine hospice stakeholders' perspectives on caring for PWD and their families.
Design:
Multisite qualitative study using semi-structured interviews with interdisciplinary hospice clinicians, leaders, and administrators. The interdisciplinary team used the constant comparative method to identify, code, and characterize relevant themes.
Setting/participants:
Four geographically distinct nonprofit U.S. hospice organizations. Fifty-one hospice employees: 61% clinical staff, 25% executive leaders, and 14% administrators.
Measurements:
Interview domains included participants' practices of engaging patients/families in discussions of preferences for end-of-life care and professional opinions of changes over time. Cross-topic probes focused on delivering hospice care to PWD and their proxies/families.
Results:
Four themes regarding caring for PWD in hospice. (1) Dementia prevalence in hospice is increasing and some hospices are developing programs to accommodate specific needs. (2) Setting impacts discussions of preferences and care decisions. (3) Caring for PWD on hospice poses unique challenges caused by (i) perceptions that dementia is not terminal, (ii) a lack of advance care planning discussions before hospice admission, and (iii) proxy decision-makers who were inadequately prepared for their role. (4) Hospice regulatory and policy changes disproportionately impact PWD.
Conclusions:
Hospice professionals perceive increasing demand for, and multilevel challenges to, caring for PWD. Clinicians “upstream” from hospice may help by engaging patients and proxies in discussions of preferences for end-of-life care and providing anticipatory guidance.
Introduction
Alzheimer'
Hospice, a model of interdisciplinary palliative care for people with a prognosis of six months or less in the United States, focuses on quality of life and provides a holistic biopsychosocial spiritual approach to advanced illness. 12 Hospice providers engage patients and family members in a process of discussing and documenting care goals, values, and preferences to create an “individualized written plan of care” for each enrollee.13–15 However, for people entering hospice with a primary diagnosis of dementia (or another serious illness with a secondary diagnosis of dementia), the verbal ability to express preferences is impaired; proxy decision-makers typically make decisions on behalf of people with advanced dementia at end of life. 16
Little is known about hospice clinician and staff perspectives on supporting and providing goal-aligned care for PWD entering hospice. As part of a larger study on hospice professionals' perspectives on and practices of eliciting preferences for end-of-life care to hospice enrollees, we explored attitudes specific to caring for PWD and their families in hospice. Findings from this study provide context for clinicians referring PWD to hospice and a foundation for future clinical and policy initiatives to improve hospice care for PWD. 17
Methods
Design
We conducted a qualitative, descriptive multisite study 18 of the practices, attitudes, and measurement of the ways in which clinicians elicit goals and values for hospice care, the provision of that care, and changes in these practices over time. Feedback from a community advisory group and methodologic experts within the Palliative Care Research Cooperative (PCRC) 19 informed refinement of the study design and interview guides. The community advisory group consisted of clinical, administrative, and caregiver stakeholders from a local nonparticipating hospice; they provided feedback on the research question and interpretation of preliminary research findings. This study was reviewed by the University of California San Francisco IRB and determined exempt.
Participants
Sites
Eligible sites were nonprofit community-based organizations providing hospice services affiliated with the PCRC and selected based on geographic diversity. Site refusal rate was 0%: the first four sites recruited agreed to participate. Individuals: Eligible hospice employees included executive leaders (i.e., presidents or vice presidents, chief executive, operating or medical officers, directors of nursing), interdisciplinary clinicians (nurses, social workers, chaplains, physicians, nurse practitioners), or quality improvement (QI) administrators. We asked sites to provide contact information for up to 30 eligible hospice staff with a range of clinical and hospice experience. Experience caring for individuals with dementia was not among the recruiting criteria. Two sites scheduled up to 15 potential participants on behalf of the researcher; the researcher scheduled participants at the other two sites. The information communicated to potential respondents and the recruitment approach were consistent across sites. See Supplementary Table S1 for more information.
Data collection
All data were collected during a two-day site visit to each of four hospices between April and September 2016 by the lead author (K.L.H.). All participants gave verbal consent before participating in a semi-structured interview whose domains included (1) contextual information about the participant and hospice organization; (2) processes and practices of eliciting and documenting preferences for care among hospice enrollees; and (3) professional opinions on eliciting/documenting preferences in the context of the hospice philosophy, including changes in practices over time. Interviews included dementia-specific probes (i.e., “how does advance care planning work with PWD?”). All participants consented to recorded and transcribed interviews except one, for whom we created a transcript-like summary. We coded interviews in ATLAS.ti version 8 (Scientific Software Development GmbH, Berlin, Germany). 20
Data analysis
First, relevant data were identified by reviewing the entire dataset and conducting keyword searches of “dementia,” “Alzheimer's,” or “cognition.” The lead author (K.L.H.) inductively open-coded these data and wrote analytic memos on emergent themes. Guided by the constant comparative method, four co-authors (K.L.H., T.A.A., S.B.G., and R.L.S.) then reviewed and discussed the data and memos. The team affirmed and iteratively refined the themes presented hereunder. Data citations in this article refer to “s,” data collection site number; “p,” participant number; and an indication of participant role or discipline, for example, leader or QI.
Results
Across the four sites, 71 individuals were recommended to the researcher for recruitment; 51 (72%) agreed to participate (4 declined, 16 did not respond). Of 51 participants, 61% were clinicians (45% nurses, 24% social workers, and 16% physicians and other providers), 25% executive leaders, and 14% QI staff; 80% were women and 88% were non-Latinx white; no one site contributed all data in a single category (Table 1). Participant demographics were similar across sites. Four themes emerged regarding caring for PWD in hospice.
Demographics of Individual Participants in Four-Site Qualitative Study, by Category
DO, doctors of osteopathic medicine; LCSW, licensed clinical social worker; LSW, licensed social worker; MD, doctor of medicine; NP, nurse practitioner; QI, quality improvement; RN, registered nurse.
Theme 1: Dementia prevalence in hospice is increasing and some hospices attempt to accommodate dementia-specific needs (Table 2)
Participants at multiple sites noted that the number of PWD receiving hospice care is increasing over time: “It is the fastest growing class of patients that we have. It's a huge issue” (site 3, participant #8, role: leader). Leaders, clinicians, and administrators across sites referred to this phenomenon. Some hospices sought to accommodate this growing population by modifying their practices and services. For example, one organization created a volunteer-based visiting program for PWD living in facilities, with plans to expand services to home settings. Motivated by new regulations for the training of long-term care staff, this site also chose to provide annual intensive dementia-specific trainings to their entire staff: “The organization committed to training everybody” (s2, p33, QI/RN). A provider at another site mentioned increased use of inpatient units to care for PWD with aspiration pneumonia, whereas a leader there mentioned increased attention to the importance of “structure and routine” in dementia care (s3, p8, leader).
Theme 1 Example Quotations: Dementia Prevalence in Hospice is Increasing and Some Hospices Attempt to Accommodate Dementia-Specific Needs
Information about the interviewee is presented following each quotation: data collection site (s), participant number (p), and the interviewee's credentials (e.g., RN, SW) or role in the organization (e.g., leader, QI).
SW, social worker.
Theme 2: Discussions of preferences and care decisions for PWD vary based on the care setting (Table 3)
Participants noted an increase in PWD receiving home hospice: “We have a large population now at home either who have care, living with their kids who have paid for private care or are taking care of them themselves” (s2, p27, leader). In these settings, participants reported it can be easier to have in-person discussions but harder to document decisions in forms. Discussions focus on helping caregivers recognize disease progression or seek help: “in the home patients, there probably is more discussion around caregiving and the stresses and strains of being able to do that for however long” (s4, p45, chaplain).
Theme 2 Example Quotations: Discussions of Preferences and Care Decisions for People with Dementia Vary Based on the Care Setting
Information about the interviewee is presented following each quotation: data collection site (s), participant number (p), and the interviewee's credentials (e.g., RN, SW) or role in the organization (e.g., leader, QI).
In nursing facilities, participants noted that forms designating proxies and code status are often required to be completed at admission to the facility. Hospice clinicians are more likely to copy those forms than to discuss preferences anew: “[for people] with ACP forms completed because the facility requires it, hospice just has to get copies” (s3, p5, QI/NP). Hospice clinicians noted the difficulty of coordinating care decisions with proxies of PWD in facility settings: “Our interactions with caregivers is much more sporadic in that setting… It's over the phone, and so that's going to right away make it more difficult to have these conversations” (s3, p5, QI/NP). At one site, participants observed that their patients living in facilities were more likely to be wards of the state because they had outlived their family members: “We do have lots of patients that do have legal guardians, wards of the state, especially facility patients…because all their family has died and there is no one” (s1, p19, RN). One participant commented that for PWD receiving hospice in assisted living, variability in settings requires tailoring care.
Theme 3: Challenges of caring for PWD on hospice (Table 4)
When participants discussed eliciting, documenting, or enacting preferences for care for hospice PWD, most referred to challenges including perceptions from families or nonhospice clinicians that dementia is not terminal, inability to discuss care preferences with PWD, or working with proxy decision-makers.
Theme 3 Example Quotations: Challenges of Caring for People with Dementia on Hospice
Information about the interviewee is presented following each quotation: data collection site (s), participant number (p), and the interviewee's credentials (e.g., RN, SW) or role in the organization (e.g., leader, QI).
PWD, people with dementia.
As one social worker said, “a lot of families did not understand that [dementia] was a terminal illness and that people end up passing because of complications of dementia, and they don't understand the disease trajectory” (s2, p31, SW). A minority of participants noted that nonhospice clinicians sometimes make recommendations for treatment that also do not seem to acknowledge the terminal nature of the disease (s2, p32, MD).
Many PWD have not engaged in discussions of care preferences before hospice admission. Although some participants reported that discussion of preferences before hospice admission is becoming more common (s2, p27, leader), others echoed this nurse's observation: “most people we get, who have had an Alzheimer's diagnosis, have had that diagnosis for many, many years, and yet… they're coming into hospice relatively unprepared for having discussions about their wishes for end of life” (s1, p25, RN). Because hospice eligibility requires a 6-month prognosis, most people entering hospice with a primary diagnosis of dementia are unable to speak: “most of them, by the time we see them, if they've not done it, they can't do it. By the time they're on hospice, their dementia is so far advanced” (s2, p27, leader). Participants suggested that clinicians upstream from hospice should start discussions of end-of-life care preferences (s2, p33, QI/RN).
Participants gave many examples of the challenges of working with families and proxy decision-makers of hospice enrollees with dementia. Some reflected the challenges of working with proxy decision-makers in general. Proxies may be unwilling to make decisions on behalf of the person with dementia: “sometimes you run into the health care proxy who's like, ‘I can't sign that, I can't sign that MOLST … I feel like I'm signing their death wish’” (s2, p38, RN). Designated proxies may not know or share the person with dementia's preferences or values (s1, p25, RN), or may disagree with others about care decisions (s2, p38, RN). Participants also discussed the challenge of working with proxies of PWD who choose different treatments than hospice clinicians would recommend: “they don't want [their parents] to die. So they do more aggressive things than I would do.” (s2, p27, leader). Participants indicated that the uncertain trajectory of dementia syndromes complicate decisions: “sometime(s) you'll hear people say, “Well, they almost died three times and they came back.” …So of course, they are going to be a little less willing to talk…or really make decisions about just “comfort care”“ (s4, p46, SW). Participants discussed the role of hospice clinicians in educating and coaching proxies and family members through potential care choices for PWD. Topics included reminding proxies of patient preferences or best interests, and teaching and providing guidance about decisions such as administering antibiotics or hospitalizations.
Theme 4: Hospice regulatory and policy changes disproportionately impact PWD (Table 5)
Participants at all sites referred to a set of Centers for Medicare and Medicaid Services (CMS) hospice regulatory changes initiated in 2013—which included discontinuing “debility” and “failure to thrive” as eligible diagnoses for hospice admission, clarifying allowable dementia diagnoses, and increasing hospice oversight—and reported that these changes limited their opportunities to care for PWD. As one participant said about dementia patients earlier in the disease course, “We could have been taking care of a lot more people a lot longer…. The people who want you the most are usually family members of dementia patients. And they're not allowed in” (s4, p41, leader).
Theme 4 Example Quotations: Hospice Regulatory and Policy Changes Disproportionately Impact People with Dementia
Information about the interviewee is presented following each quotation: data collection site (s), participant number (p), and the interviewee's credentials (e.g., RN, SW) or role in the organization (e.g., leader, QI).
CMS, Centers for Medicare and Medicaid Services; FAST, Functional Assessment Staging Test; ICD, International Classification of Diseases; MRI, magnetic resonance imaging; PPS, Palliative Performance Scale.
Participants described the ways that the policy context, such as organizational payment concerns, shaped the provision of hospice care for PWD. One participant explained: “Because those patients [with dementia] are alive longer, they're often in a very debilitated state for a very long time, and the cost is more to care for them in hospice than without hospice” (s1, p24, leader). Some described hospice teams as “being more aggressive with discharge planning” because of concerns about their meeting criteria for ongoing hospice eligibility (s4, p45, chaplain). Participants spoke of their discomfort with live discharges and its impact on goal-aligned care for patients and families: “it's kind of harder to keep people on hospice longer and I think people are struggling with that. And if you take away hospice, that changes the goals of care conversation just by the nature of who's going to get called in the middle of the night” (s1, p23, SW). Leaders at multiple sites opined on motivations for prior (s4, p41) and future (s1, p24) hospice policy changes. In discussing policy change, participants referenced its impacts on PWD far more than any other population.
Discussion
In this study, we found that hospice professionals at four participating sites perceived the prevalence of PWD in hospice to be increasing. Some organizations created programs or practices to accommodate these patients. Eliciting preferences for end-of-life care or providing preference-aligned care varied by care setting. Challenges of serving PWD included the timing of discussing and documenting preferences, perceptions that dementia is not terminal, and working with proxies who may not understand the patient's prognosis, their wishes, or may be unwilling to make decisions. Hospice regulatory changes have complicated initial and ongoing hospice eligibility for PWD, and live discharge limits available services. Overall, the data suggest that demand for hospice for PWD has increased as regulatory pressures have made it more difficult to serve those needs. To our knowledge, this is one of the first studies to use hospice staff perspectives to elucidate these topics.
CMS hospice regulatory changes from 2013 figured prominently in participant responses. 21 These changes, including clarifying ICD-9 (International Classification of Diseases, Ninth Revision) diagnoses and discontinuing some eligible principal diagnoses, were intended to improve the accuracy of hospice data, inform payment reform, and facilitate greater oversight of hospice organizations to discourage their prioritizing revenue over patient care—for example, by selectively enrolling people likely to have long lengths of stay with low acuity needs, such as PWD.22–24 However, the effect of these policy changes on hospice patient care is uncertain. PWD on hospice experience higher rates of disenrollment after a stay of 165 days or longer than do people with other serious illnesses, which creates additional care transitions and burdens for family caregivers.25–27 Of importance, many of our study participants felt these regulatory changes limited their ability to care for PWD and their caregivers.
Hospice professionals in our study illuminated the ways in which PWD do not adequately prepare for end of life, either by discussing preferences when they still have decisional capacity or by supporting and preparing proxy decision-makers. A recent international systematic review on advance care planning and end-of-life care among PWD and their caregivers found that individuals in these groups often procrastinate advance care planning, perceiving no urgency. 27 Indeed, previous research suggests community-dwelling older adults with dementia in the United States are less likely than those without dementia to have engaged in discussions of end-of-life preferences or completed advance directives. 28 Some study participants described a desire for clinicians upstream to begin these conversations earlier in the disease course. Although health care in the United States is a product of the regulatory structure, the issues outlined here of proxy decision-making, the recognition of dementia progression in the hectic context of daily caregiving, and the need for advance care planning earlier in the disease course in this population are relevant issues for PWD around the world. A number of studies are in progress to test mechanisms to engage PWD and/or potential proxy decision-makers in advance care planning discussions.29–34 Parallel efforts are needed to support nonhospice clinicians to feel motivated and capable to encourage PWD and their potential proxies to discuss preferences and obtain anticipatory guidance about end-of-life care decisions.35–37
Limitations
The findings from this study emanated from a sample of interdisciplinary hospice staff within a sample of four nonprofit hospice organizations. Participants were primarily medically trained hospice clinicians and social workers; research with a wider range of hospice leaders and chaplains, or individuals who specialize in caring for hospice patients with dementia, may yield additional themes. We identified themes related to dementia in the context of a broader conversation about advance care planning. Findings may not be transferable to for-profit hospice organizations,38,39 although this should be explored. Aspects of hospice and advance care planning unique to the U.S. health care system, such as Medicare Hospice Benefit regulatory requirements and documentation of preferences in forms in facilities, are not generalizable to other nations.
Nevertheless, this study provides important insights from a broad range of hospice professionals on providing preference-aligned end-of-life care to PWD. Their perspectives reiterate a need for all clinicians to engage PWD in discussions about their values and preferences early in the disease process, and to support families and proxies through the process of making end-of-life care decisions. Hospice professionals also highlight opportunities to improve policy and educate families and clinicians.
Footnotes
Acknowledgments
The authors appreciate the time invested by participants and administrators at the four hospice organizations and members of our community advisory group. We would like to thank the Palliative Care Research Cooperative (PCRC) leaders and members of our community advisory group for their formative feedback on study design, and MSTAR (Medical Student Training in Aging Research) student Gaby Dressler for her feedback on manuscript drafts. Preliminary findings were presented by Nicole Thompson at the International Conference of Alzheimer's Disease International (ADI) on July 27, 2018. Dr. Harrison has obtained written consent from all contributors named here.
Sponsor's Role
Experts from the Palliative Care Research Cooperative (PCRC) Group, funded by National Institute of Nursing Research (U24NR014637), provided consultations about the design and methods. Sponsors were not directly involved in the design, methods, subject recruitment, data collection, analysis or preparation of the article.
Funding Information
This study was conducted with the support of funding awarded to Dr. Harrison from a pilot award from the Palliative Care Research Cooperative (PCRC) Group funded by National Institute of Nursing Research (U24NR014637); Research Fellowship from the National Institute of Aging (T32AG000212); Atlantic Fellowship of the Global Brain Health Institute; UCSF Hellman Fellows Award; pilot award from the UCSF Claude D. Pepper Older Americans Independence Center funded by National Institute on Aging (P30 AG044281); Career Development Award from the National Center for Advancing Translational Sciences of the NIH (KL2TR001870); National Palliative Care Research Center Junior Faculty Award; and National Institute of Aging Mentored Research Scientist Development Award (K01AG059831).
. is funded in part by National Institute on Aging (K24AG054415). The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in development of the study, data acquisition, data interpretation, writing, or editing of article.
Author Disclosure Statement
The authors have no commercial interests or conflicts of interest, actual or potential, to disclose.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
